Asthma Management Handbook
Close window

Table. Pregnancy safety categories for asthma and allergic rhinitis medicines

 

Category A

Category B1

Category B3

Category C

Relievers †

Salbutamol sulfate (most formulations)

Terbutaline sulfate
Salbutamol sulfate (Airomir)    

Preventers: ICS

Budesonide  

Beclometasone dipropionate

Ciclesonide

Fluticasone furoate

Fluticasone propionate

 

Preventers: ICS/LABA combinations

   

Budesonide/formoterol fumarate dihydrate

Fluticasone/formoterol

Fluticasone furoate /vilanterol trifenatate

Fluticasone propionate/salmeterol xinafoate
 

Preventers: other

 

Montelukast sodium

Sodium cromoglycate ‡

   

Systemic corticosteroids

Methylprednisolone sodium succinate

Prednisolone

Prednisone
    Hydrocortisone sodium succinate

Other bronchodilators

Adrenaline acid tartrate

Adrenaline hydrochloride

Aminophylline

Theophylline

Ipratropium bromide

Tiotropium bromide

   

Other asthma medicines

 

Omalizumab

Mepolizumab

   

Allergic rhinitis nasal sprays ‡

Budesonide

Ipratropium bromide

Azelastine

Beclometasone

Ciclesonide

Fluticasone furoate

Fluticasone propionate

Levocabastine

Mometasone

 

Potential risks and benefits to mother and foetus must be considered before using any medicine. This table shows pregnancy safety categories from TGA-approved product information; during pregnancy, the risk to the foetus from uncontrolled asthma in the mother should also be taken into account. Untreated asthma, poorly controlled asthma or flare-ups during pregnancy put mothers and babies at risk.

† Budesonide/formoterol combination can also be used as a reliever

Intal Spincaps and Rynacrom formulations of sodium cromoglycate are Category A

Sources:
TGA-approved product information. Available at: https://www.tga.gov.au/product-information-pi
TGA Prescribing medicines in pregnancy database. Available at: https://www.tga.gov.au/prescribing-medicines-pregnancy-database

Back to top

Asset ID: 44